Sökning: onr:"swepub:oai:lup.lub.lu.se:faeb53da-35b2-481c-ba91-a07cec8fa298" >
Impact of the COVID...
Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study
-
- Armario, X. (författare)
- Galway University Hospital
-
- Götberg, M. (författare)
- Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine
-
- McEvoy, J.W. (författare)
- Galway University Hospital
-
visa fler...
-
- Mylotte, D. (författare)
- Galway University Hospital
-
visa färre...
-
(creator_code:org_t)
-
et al
- 2024
- 2024
- Engelska 14 s.
-
Ingår i: JACC: Cardiovascular Interventions. - 1936-8798. ; 17:3, s. 374-387
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: The COVID-19 pandemic adversely affected health care systems. Patients in need of transcatheter aortic valve replacement (TAVR) are especially susceptible to treatment delays. Objectives: This study sought to evaluate the impact of the COVID-19 pandemic on global TAVR activity. Methods: This international registry reported monthly TAVR case volume in participating institutions prior to and during the COVID-19 pandemic (January 2018 to December 2021). Hospital-level information on public vs private, urban vs rural, and TAVR volume was collected, as was country-level information on socioeconomic status, COVID-19 incidence, and governmental public health responses. Results: We included 130 centers from 61 countries, including 65,980 TAVR procedures. The first and second pandemic waves were associated with a significant reduction of 15% (P < 0.001) and 7% (P < 0.001) in monthly TAVR case volume, respectively, compared with the prepandemic period. The third pandemic wave was not associated with reduced TAVR activity. A greater reduction in TAVR activity was observed in Africa (−52%; P = 0.001), Central-South America (−33%; P < 0.001), and Asia (−29%; P < 0.001). Private hospitals (P = 0.005), urban areas (P = 0.011), low-volume centers (P = 0.002), countries with lower development (P < 0.001) and economic status (P < 0.001), higher COVID-19 incidence (P < 0.001), and more stringent public health restrictions (P < 0.001) experienced a greater reduction in TAVR activity. Conclusions: TAVR procedural volume declined substantially during the first and second waves of the COVID-19 pandemic, especially in Africa, Central-South America, and Asia. National socioeconomic status, COVID-19 incidence, and public health responses were associated with treatment delays. This information should inform public health policy in case of future global health crises.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Public Health, Global Health, Social Medicine and Epidemiology (hsv//eng)
Nyckelord
- aortic valve stenosis
- coronavirus disease 2019
- transcatheter aortic valve replacement
- valvular heart disease
- Aortic Valve
- Aortic Valve Stenosis
- COVID-19
- Humans
- Pandemics
- Registries
- Risk Factors
- Transcatheter Aortic Valve Replacement
- Treatment Outcome
- Africa
- Article
- Asia
- controlled study
- disease registry
- human
- incidence
- major clinical study
- observational study
- pandemic
- private hospital
- rural area
- social status
- South America
- urban area
- valve-in-valve transcatheter aortic valve implantation
- volume
- aortic valve
- diagnostic imaging
- procedures
- register
- risk factor
- transcatheter aortic valve implantation
- treatment outcome
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas